Literature DB >> 29063337

Mast Cells in Renal Cancer: Clinical Morphological Correlations and Prognosis.

T M Cherdantseva1, I P Bobrov1,2, A M Avdalyan2, V V Klimachev1, A V Kazartsev1, N G Kryuchkova1, I V Klimachev1, M N Myadelets1, A V Lepilov1, E L Lushnikova3, O P Molodykh1.   

Abstract

Morphofunctional activity of mast cells in renal cancer is studied on specimens from the center of the tumor, peritumorous zone (with an obligatory fragment of the pseudocapsule), and from renal tissues maximally distant from the tumor. The counts and areas of tumor cells were maximum in the peritumorous zone in comparison with intact kidney tissue and central zone of the tumor. Analysis of correlations revealed a direct correlation between the tumor cell count in the peritumorous zone and some clinical morphological parameters of the tumor (anaplasia degree, size, presence of invasion and metastases, and angiogenesis). The count of mast cells in the renal peritumorous zone inversely correlated with 5-year survival: 100% cumulative 5-year survival in patients with mast cell count <6.7±1.6 per field of view.

Entities:  

Keywords:  5-year survival; angiogenesis; mast cells; peritumorous zone; renal cancer

Mesh:

Substances:

Year:  2017        PMID: 29063337     DOI: 10.1007/s10517-017-3907-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  10 in total

1.  A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients.

Authors:  Yanling Yu; Jing Tian; Yanni Hou; Xinxin Zhang; Linhua Li; Peifu Cong; Lei Ji; Xuri Wang
Journal:  World J Surg Oncol       Date:  2022-07-08       Impact factor: 3.253

Review 2.  Role of Mast Cells in Shaping the Tumor Microenvironment.

Authors:  Daniel Elieh Ali Komi; Frank A Redegeld
Journal:  Clin Rev Allergy Immunol       Date:  2020-06       Impact factor: 8.667

Review 3.  Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth.

Authors:  Deisy Segura-Villalobos; Itzel G Ramírez-Moreno; Magnolia Martínez-Aguilar; Alfredo Ibarra-Sánchez; J Omar Muñoz-Bello; Isabel Anaya-Rubio; Alejandro Padilla; Marina Macías-Silva; Marcela Lizano; Claudia González-Espinosa
Journal:  Cells       Date:  2022-01-20       Impact factor: 6.600

Review 4.  Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.

Authors:  Mohammad Fereydouni; Mona Motaghed; Elnaz Ahani; Tal Kafri; Kristen Dellinger; Dean D Metcalfe; Christopher L Kepley
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

5.  Endoplasmic Reticulum Stress-Related Signature Predicts Prognosis and Drug Response in Clear Cell Renal Cell Carcinoma.

Authors:  Yuke Zhang; Yancheng Song; Jiangwen Dai; Zhaoxiang Wang; Yuhao Zeng; Feng Chen; Peng Zhang
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988

6.  Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway.

Authors:  Xiangyu Che; Jianyi Li; Yingkun Xu; Qifei Wang; Guangzhen Wu
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

7.  M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.

Authors:  Xiaodong Qu; Xingyu Zhao; Kexin Lin; Na Wang; Xuezhi Li; Songbo Li; Luyao Zhang; Yongquan Shi
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

8.  Mast Cells and Blood Vessels Profile in Oral Carcinogenesis: An Immunohistochemistry Study.

Authors:  Carolina Rodrigues Teófilo; Antonio Ernando Carlos Ferreira Junior; Aline Carvalho Batista; Francisco Vagnaldo Fechini Jamacaru; Fabricio Bitu Sousa; Mário Rogério Lima Mota; Malena Freitas E Silva; Paulo Goberlânio De Barros Silva; Ana Paula Negreiros Nunes Alves
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01

9.  Immune classification of clear cell renal cell carcinoma.

Authors:  Sumeyye Su; Shaya Akbarinejad; Leili Shahriyari
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

10.  Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.

Authors:  Yuke Zhang; Jiangwen Dai; Weifeng Huang; Qingsong Chen; Wei Chen; Qiying He; Feng Chen; Peng Zhang
Journal:  Aging (Albany NY)       Date:  2021-12-27       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.